Related Experiment Video
Updated: Sep 10, 2025

Refined Murine Model of Idiopathic Pulmonary Fibrosis
Published on: June 17, 2025
Changes in Lung Function and Patient-Reported Outcomes in Patients with Idiopathic Pulmonary Fibrosis
Jamie L Todd1,2, Megan L Neely3,4, Anne S Hellkamp3,4
1Duke Clinical Research Institute, Durham, NC, USA. jamie.todd@duke.edu.
Changes in lung function show weak correlations with patient-reported outcomes in idiopathic pulmonary fibrosis (IPF). Assessing both lung function and health-related quality of life (HRQL) is crucial for IPF clinical trials and practice.
Area of Science:
- Pulmonology
- Clinical Research
- Patient-Reported Outcomes
Background:
- Idiopathic pulmonary fibrosis (IPF) is a progressive lung disease with significant impact on patients' quality of life.
- Understanding the relationship between objective lung function measures and subjective patient experiences is vital for comprehensive disease management.
Purpose of the Study:
- To evaluate the correlations between changes in lung function parameters and patient-reported outcomes (PROs) over 12 months in IPF patients.
- To determine if changes in specific PROs predict declines in lung function in IPF.
Main Methods:
- Analysis of data from 736 patients with IPF in the IPF-PRO Registry.
- Assessment of changes in forced vital capacity (FVC) and diffusing capacity of the lungs for carbon monoxide (DLco).
- Evaluation of changes in St George's Respiratory Questionnaire (SGRQ) and 12-item Short Form Survey (SF-12) physical component summary (PCS) scores.
Main Results:
- Weak correlations were found between changes in lung function (FVC, DLco) and changes in SGRQ and SF-12 PCS scores over 12 months.
- Patients with a deterioration of ≥5 units in SGRQ activity or SF-12 PCS scores showed numerically larger lung function declines, but the differences were small.
- The observed relationships between lung function changes and PROs were not strong.
Conclusions:
- The weak associations highlight the need to consider both lung function and health-related quality of life (HRQL) measures independently.
- Comprehensive evaluation of both objective lung function and subjective PROs is essential in IPF clinical practice and trials.
- Future research should explore factors influencing the discordance between lung function and HRQL in IPF.
Related Concept Videos
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
Pulmonary Function Tests
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Chronic Obstructive Pulmonary Disease-I: Introduction

